Molecular Imaging of Alzheimer's Disease-Related Sigma-1 Receptor in the Brain via a Novel Ru-Mediated Aromatic 18F-deoxyfluorination Probe

J Med Chem. 2024 Apr 25;67(8):6207-6217. doi: 10.1021/acs.jmedchem.3c02178. Epub 2024 Apr 12.

Abstract

Sigma-1 receptor (σ1R) is an intracellular protein implicated in a spectrum of neurodegenerative conditions, notably Alzheimer's disease (AD). Positron emission tomography (PET) imaging of brain σ1R could provide a powerful tool for better understanding the underlying pathomechanism of σ1R in AD. In this study, we successfully developed a 18F-labeled σ1R radiotracer [18F]CNY-05 via an innovative ruthenium (Ru)-mediated 18F-deoxyfluorination method. [18F]CNY-05 exhibited preferable brain uptake, high specific binding, and slightly reversible pharmacokinetics within the PET scanning time window. PET imaging of [18F]CNY-05 in nonhuman primates (NHP) indicated brain permeability, metabolic stability, and safety. Moreover, autoradiography and PET studies of [18F]CNY-05 in the AD mouse model found a significantly decreased brain uptake compared to that in wild-type mice. Collectively, we have provided a novel 18F-radiolabeled σ1R PET probe, which enables visualizing brain σ1R in health and neurological diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / metabolism
  • Animals
  • Brain* / diagnostic imaging
  • Brain* / metabolism
  • Fluorine Radioisotopes* / chemistry
  • Halogenation
  • Humans
  • Male
  • Mice
  • Molecular Imaging / methods
  • Positron-Emission Tomography* / methods
  • Radiopharmaceuticals* / chemical synthesis
  • Radiopharmaceuticals* / chemistry
  • Radiopharmaceuticals* / pharmacokinetics
  • Receptors, sigma* / metabolism
  • Sigma-1 Receptor*
  • Tissue Distribution

Substances

  • Receptors, sigma
  • Sigma-1 Receptor
  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Fluorine-18